Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lisa Rankin
Institutions:
Harvard University,
Alzheimer’s Disease Neuroimaging Initiative
Observed institutions:
Harvard University,
Alzheimer’s Disease Neuroimaging Initiative
OpenAlex ID:
A5072717345
Radionuclide imaging technologies and their use in evaluating asthma drug deposition in the lungs
2003
·
Stephen P. Newman
, Gary R. Pitcairn
, et al.
·
Advanced Drug Delivery Reviews
·
94
Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment
2026
·
Rachel F. Buckley
, Diana L. Townsend
, et al.
·
JAMA
·
23
PDF
Pulmonary and nasal deposition of ketorolac tromethamine solution (SPRIX) following intranasal administration
2012
·
Rachel Bacon
, Steve Newman
, et al.
·
International Journal of Pharmaceutics
·
17
Deep learning enhanced ALPS reveals genetic and environmental factors of brain glymphatic function
2026
·
Cha Lin
, Hao Wu
, et al.
·
EBioMedicine
·
8
Sex and APOE genotype specific brain regional vulnerability to Alzheimer's Disease
2026
·
Qi Zeng
, Minghui Wang
, et al.
·
GeroScience
·
3
PDF
Alzheimer Disease–Relevant Biomarker Elevations in Psychosis and Broad Neuropsychiatric Impairment
2026
·
Michael J. C. Bray
, Jacob S. Shaw
, et al.
·
JAMA Psychiatry
·
2
Mutual learning for joint disease detection and severity prediction reveals multimodal pathogenesis for neurodegenerative disorders
2025
·
Jin Zhang
, Yixin Ji
, et al.
·
Bioinformatics
·
1
PDF
Absolute Risk of Progression to Cognitive Impairment Based on Plasma Phosphorylated Tau 217, Age, Sex, and APOE ε4
2026
·
Alicia Algeciras-Schimnich
, Mingzhao Hu
, et al.
·
JAMA Neurology
Interpretable deep learning reveals spatiotemporal MRI features of brain aging that align with neurodegeneration
2026
·
Nikhil N. Chaudhari
, Owen M. Vega
, et al.
·
GeroScience
PDF
Show more works
View as search
Works count:
9
Citation count:
148
H-index:
4
I10-index:
3
Year
Topic
Type